Semaglutide Goes Generic in India: Drugs could be as cheap as $14 | Vantage with Palki Sharma | N18G

India has just entered its Ozempic era. With the patent expiry of Semaglutide, the key ingredient behind blockbuster drugs like Ozempic and Wegovy, prices are set to crash as dozens of local pharma companies launch generics. This could make a life-changing treatment for obesity and diabetes accessible to millions. But there’s a catch. India’s culture of self-medication, weak prescription enforcement, and concerns around generic quality could turn this breakthrough into a public health risk. Is this a long-awaited healthcare win—or the beginning of a dangerous free-for-all? --- Ozempic | Semaglutide | Ozempic Generic Launch India | Wegovy Diabetes Treatment India | India Pharma Industry News | Firstpost | World News | News Live | Vantage | Palki Sharma | News #ozempic #semaglutide #diabetes #obesity #firstpost #vantageonfirstpost #palkisharma #worldnews Vantage is a ground-breaking news, opinions, and current affairs show from Firstpost. Catering to a global audience, Vantage covers the biggest news stories from a 360-degree perspective, giving viewers a chance to assess the impact of world events through a uniquely Indian lens. The show is anchored by Palki Sharma, Managing Editor, Firstpost. By breaking stereotypes, Vantage aims to challenge conventional wisdom and present an alternative view on global affairs, defying the norm and opening the door to new perspectives. The show goes beyond the headlines to uncover the hidden stories – making Vantage a destination for thought-provoking ideas. Vantage airs Monday to Friday at 9 PM IST on Firstpost across all leading platforms. ​ Subscribe to Firstpost channel and press the bell icon to get notified when we go live.    / @firstpost   Follow Firstpost on Instagram:   / firstpost   Follow Firstpost on Facebook:   / firstpostin   Follow Firstpost on Twitter:   / firstpost   Follow Firstpost on WhatsApp: https://www.whatsapp.com/channel/0029...